Profiles Header - Harvard Catalyst Profiles Header – Harvard Catalyst

Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Dorene May Rentz, Psy.D.

Title
Institution
Department
Address
Phone
Fax

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. P01AG036694 (SPERLING, REISA A.) Jul 15, 2010 - Mar 31, 2020
    NIH/NIA
    Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study
    Role: Co-Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Chhatwal JP, Schultz AP, Hedden T, Boot BP, Wigman S, Rentz D, Johnson KA, Sperling RA. Anticholinergic Amnesia is Mediated by Alterations in Human Network Connectivity Architecture. Cereb Cortex. 2018 Sep 06. PMID: 30192928.
    View in: PubMed
  2. Amariglio RE, Buckley RF, Mormino EC, Marshall GA, Johnson KA, Rentz DM, Sperling RA. Amyloid-associated increases in longitudinal report of subjective cognitive complaints. Alzheimers Dement (N Y). 2018; 4:444-449. PMID: 30258973.
    View in: PubMed
  3. Rabin JS, Schultz AP, Hedden T, Viswanathan A, Marshall GA, Kilpatrick E, Klein H, Buckley RF, Yang HS, Properzi M, Rao V, Kirn DR, Papp KV, Rentz DM, Johnson KA, Sperling RA, Chhatwal JP. Interactive Associations of Vascular Risk and ß-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study. JAMA Neurol. 2018 Sep 01; 75(9):1124-1131. PMID: 29799986.
    View in: PubMed
  4. Hanseeuw BJ, Jonas V, Jackson J, Betensky RA, Rentz DM, Johnson KA, Sperling RA, Donovan NJ. Association of anxiety with subcortical amyloidosis in cognitively normal older adults. Mol Psychiatry. 2018 Aug 16. PMID: 30116029.
    View in: PubMed
  5. Buckley RF, Mormino EC, Amariglio RE, Properzi MJ, Rabin JS, Lim YY, Papp KV, Jacobs HIL, Burnham S, Hanseeuw BJ, Doré V, Dobson A, Masters CL, Waller M, Rowe CC, Maruff P, Donohue MC, Rentz DM, Kirn D, Hedden T, Chhatwal J, Schultz AP, Johnson KA, Villemagne VL, Sperling RA. Sex, amyloid, and APOE e4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts. Alzheimers Dement. 2018 Sep; 14(9):1193-1203. PMID: 29803541.
    View in: PubMed
  6. Hanseeuw BJ, Betensky RA, Mormino EC, Schultz AP, Sepulcre J, Becker JA, Jacobs HIL, Buckley RF, LaPoint MR, Vannini P, Donovan NJ, Chhatwal JP, Marshall GA, Papp KV, Amariglio RE, Rentz DM, Sperling RA, Johnson KA. PET staging of amyloidosis using striatum. Alzheimers Dement. 2018 Oct; 14(10):1281-1292. PMID: 29792874.
    View in: PubMed
  7. Munro CE, Donovan NJ, Amariglio RE, Papp KV, Marshall GA, Rentz DM, Pascual-Leone A, Sperling RA, Locascio JJ, Vannini P. The Impact of Awareness of and Concern About Memory Performance on the Prediction of Progression From Mild Cognitive Impairment to Alzheimer Disease Dementia. Am J Geriatr Psychiatry. 2018 Aug; 26(8):896-904. PMID: 29866588.
    View in: PubMed
  8. Sanabria A, Alegret M, Rodriguez-Gomez O, Valero S, Sotolongo-Grau O, Monté-Rubio G, Abdelnour C, Espinosa A, Ortega G, Perez-Cordon A, Gailhajanet A, Hernandez I, Rosende-Roca M, Vargas L, Mauleon A, Sanchez D, Martin E, Rentz DM, Lomeña F, Ruiz A, Tarraga L, Boada M. The Spanish version of Face-Name Associative Memory Exam (S-FNAME) performance is related to amyloid burden in Subjective Cognitive Decline. Sci Rep. 2018 Feb 28; 8(1):3828. PMID: 29491481.
    View in: PubMed
  9. Jacobs HIL, Hedden T, Schultz AP, Sepulcre J, Perea RD, Amariglio RE, Papp KV, Rentz DM, Sperling RA, Johnson KA. Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals. Nat Neurosci. 2018 Mar; 21(3):424-431. PMID: 29403032.
    View in: PubMed
  10. Donovan NJ, Locascio JJ, Marshall GA, Gatchel J, Hanseeuw BJ, Rentz DM, Johnson KA, Sperling RA. Longitudinal Association of Amyloid Beta and Anxious-Depressive Symptoms in Cognitively Normal Older Adults. Am J Psychiatry. 2018 Jun 01; 175(6):530-537. PMID: 29325447.
    View in: PubMed
  11. Guzmán-Vélez E, Jaimes S, Aguirre-Acevedo DC, Norton DJ, Papp KV, Amariglio R, Rentz D, Baena A, Henao E, Tirado V, Muñoz C, Giraldo M, Sperling RA, Lopera F, Quiroz YT. A Three-Factor Structure of Cognitive Functioning Among Unimpaired Carriers and Non-Carriers of Autosomal-Dominant Alzheimer's Disease. J Alzheimers Dis. 2018; 65(1):107-115. PMID: 30040714.
    View in: PubMed
  12. Buckley RF, Hanseeuw B, Schultz AP, Vannini P, Aghjayan SL, Properzi MJ, Jackson JD, Mormino EC, Rentz DM, Sperling RA, Johnson KA, Amariglio RE. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global ß-Amyloid Burden. JAMA Neurol. 2017 Dec 01; 74(12):1455-1463. PMID: 28973551.
    View in: PubMed
  13. Orlovsky I, Huijbers W, Hanseeuw BJ, Mormino EC, Hedden T, Buckley RF, LaPoint M, Rabin JS, Rentz DM, Johnson KA, Sperling RA, Papp KV. The relationship between recall of recently versus remotely encoded famous faces and amyloidosis in clinically normal older adults. Alzheimers Dement (Amst). 2018; 10:121-129. PMID: 29780861.
    View in: PubMed
  14. Papp KV, Rentz DM, Orlovsky I, Sperling RA, Mormino EC. Optimizing the preclinical Alzheimer's cognitive composite with semantic processing: The PACC5. Alzheimers Dement (N Y). 2017 Nov; 3(4):668-677. PMID: 29264389.
    View in: PubMed
  15. Jackson JD, Rentz DM, Aghjayan SL, Buckley RF, Meneide TF, Sperling RA, Amariglio RE. Subjective cognitive concerns are associated with objective memory performance in Caucasian but not African-American persons. Age Ageing. 2017 Nov 01; 46(6):988-993. PMID: 29088363.
    View in: PubMed
  16. Huijbers W, Papp KV, LaPoint M, Wigman SE, Dagley A, Hedden T, Rentz DM, Schultz AP, Sperling RA. Age-Related Increases in Tip-of-the-tongue are Distinct from Decreases in Remembering Names: A Functional MRI Study. Cereb Cortex. 2017 09 01; 27(9):4339-4349. PMID: 27578492.
    View in: PubMed
  17. Bott NT, Lange A, Rentz D, Buffalo E, Clopton P, Zola S. Web Camera Based Eye Tracking to Assess Visual Memory on a Visual Paired Comparison Task. Front Neurosci. 2017; 11:370. PMID: 28701915.
    View in: PubMed
  18. Buckley RF, Schultz AP, Hedden T, Papp KV, Hanseeuw BJ, Marshall G, Sepulcre J, Smith EE, Rentz DM, Johnson KA, Sperling RA, Chhatwal JP. Functional network integrity presages cognitive decline in preclinical Alzheimer disease. Neurology. 2017 Jul 04; 89(1):29-37. PMID: 28592457.
    View in: PubMed
  19. Vannini P, Hanseeuw B, Munro CE, Amariglio RE, Marshall GA, Rentz DM, Pascual-Leone A, Johnson KA, Sperling RA. Anosognosia for memory deficits in mild cognitive impairment: Insight into the neural mechanism using functional and molecular imaging. Neuroimage Clin. 2017; 15:408-414. PMID: 28616381.
    View in: PubMed
  20. Dekhtyar M, Papp KV, Buckley R, Jacobs HIL, Schultz AP, Johnson KA, Sperling RA, Rentz DM. Neuroimaging markers associated with maintenance of optimal memory performance in late-life. Neuropsychologia. 2017 06; 100:164-170. PMID: 28472627.
    View in: PubMed
  21. Hanseeuw BJ, Betensky RA, Schultz AP, Papp KV, Mormino EC, Sepulcre J, Bark JS, Cosio DM, LaPoint M, Chhatwal JP, Rentz DM, Sperling RA, Johnson KA. Fluorodeoxyglucose metabolism associated with tau-amyloid interaction predicts memory decline. Ann Neurol. 2017 Apr; 81(4):583-596. PMID: 28253546.
    View in: PubMed
  22. Vannini P, Hanseeuw B, Munro CE, Amariglio RE, Marshall GA, Rentz DM, Pascual-Leone A, Johnson KA, Sperling RA. Hippocampal hypometabolism in older adults with memory complaints and increased amyloid burden. Neurology. 2017 May 02; 88(18):1759-1767. PMID: 28381517.
    View in: PubMed
  23. Vannini P, Amariglio R, Hanseeuw B, Johnson KA, McLaren DG, Chhatwal J, Pascual-Leone A, Rentz D, Sperling RA. Memory self-awareness in the preclinical and prodromal stages of Alzheimer's disease. Neuropsychologia. 2017 05; 99:343-349. PMID: 28385579.
    View in: PubMed
  24. Rentz DM, Mormino EC, Papp KV, Betensky RA, Sperling RA, Johnson KA. Cognitive resilience in clinical and preclinical Alzheimer's disease: the Association of Amyloid and Tau Burden on cognitive performance. Brain Imaging Behav. 2017 04; 11(2):383-390. PMID: 27738998.
    View in: PubMed
  25. Rentz DM, Weiss BK, Jacobs EG, Cherkerzian S, Klibanski A, Remington A, Aizley H, Goldstein JM. Sex differences in episodic memory in early midlife: impact of reproductive aging. Menopause. 2017 04; 24(4):400-408. PMID: 27824681.
    View in: PubMed
  26. Papp KV, Rentz DM, Mormino EC, Schultz AP, Amariglio RE, Quiroz Y, Johnson KA, Sperling RA. Cued memory decline in biomarker-defined preclinical Alzheimer disease. Neurology. 2017 Apr 11; 88(15):1431-1438. PMID: 28283594.
    View in: PubMed
  27. Mormino EC, Papp KV, Rentz DM, Donohue MC, Amariglio R, Quiroz YT, Chhatwal J, Marshall GA, Donovan N, Jackson J, Gatchel JR, Hanseeuw BJ, Schultz AP, Aisen PS, Johnson KA, Sperling RA. Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid ß. Alzheimers Dement. 2017 Sep; 13(9):1004-1012. PMID: 28253478.
    View in: PubMed
  28. Gatchel JR, Donovan NJ, Locascio JJ, Becker JA, Rentz DM, Sperling RA, Johnson KA, Marshall GA. Regional 18F-Fluorodeoxyglucose Hypometabolism is Associated with Higher Apathy Scores Over Time in Early Alzheimer Disease. Am J Geriatr Psychiatry. 2017 Jul; 25(7):683-693. PMID: 28410856.
    View in: PubMed
  29. Gatchel JR, Donovan NJ, Locascio JJ, Schultz AP, Becker JA, Chhatwal J, Papp KV, Amariglio RE, Rentz DM, Blacker D, Sperling RA, Johnson KA, Marshall GA. Depressive Symptoms and Tau Accumulation in the Inferior Temporal Lobe and Entorhinal Cortex in Cognitively Normal Older Adults: A Pilot Study. J Alzheimers Dis. 2017; 59(3):975-985. PMID: 28697559.
    View in: PubMed
  30. Marshall GA, Aghjayan SL, Dekhtyar M, Locascio JJ, Jethwani K, Amariglio RE, Johnson KA, Sperling RA, Rentz DM. Activities of daily living measured by the Harvard Automated Phone Task track with cognitive decline over time in non-demented elderly. J Prev Alzheimers Dis. 2017; 4(2):81-86. PMID: 29124043.
    View in: PubMed
  31. Kahle-Wrobleski K, Andrews JS, Belger M, Ye W, Gauthier S, Rentz DM, Galasko D. Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study. J Prev Alzheimers Dis. 2017; 4(2):72-80. PMID: 29186278.
    View in: PubMed
  32. Buckley RF, Sparks KP, Papp KV, Dekhtyar M, Martin C, Burnham S, Sperling RA, Rentz DM. Computerized Cognitive Testing for Use in Clinical Trials: A Comparison of the NIH Toolbox and Cogstate C3 Batteries. J Prev Alzheimers Dis. 2017; 4(1):3-11. PMID: 29188853.
    View in: PubMed
  33. Donovan NJ, Okereke OI, Vannini P, Amariglio RE, Rentz DM, Marshall GA, Johnson KA, Sperling RA. Association of Higher Cortical Amyloid Burden With Loneliness in Cognitively Normal Older Adults. JAMA Psychiatry. 2016 Dec 01; 73(12):1230-1237. PMID: 27806159.
    View in: PubMed
  34. Aghjayan SL, Buckley RF, Vannini P, Rentz DM, Jackson JD, Sperling RA, Johnson KA, Amariglio RE. The influence of demographic factors on subjective cognitive concerns and beta-amyloid. Int Psychogeriatr. 2017 04; 29(4):645-652. PMID: 27724996.
    View in: PubMed
  35. Nevarez MD, Malone JC, Rentz DM, Waldinger RJ. War and remembrance: Combat exposure in young adulthood and memory function sixty years later. Compr Psychiatry. 2017 01; 72:97-105. PMID: 27776275.
    View in: PubMed
  36. Mormino EC, Papp KV, Rentz DM, Schultz AP, LaPoint M, Amariglio R, Hanseeuw B, Marshall GA, Hedden T, Johnson KA, Sperling RA. Heterogeneity in Suspected Non-Alzheimer Disease Pathophysiology Among Clinically Normal Older Individuals. JAMA Neurol. 2016 Oct 01; 73(10):1185-1191. PMID: 27548655.
    View in: PubMed
  37. Rentz DM. Validating Use of Technology for Cognitive Test Assessment. EBioMedicine. 2016 Sep; 11:23-24. PMID: 27498366.
    View in: PubMed
  38. Hsu DC, Mormino EC, Schultz AP, Amariglio RE, Donovan NJ, Rentz DM, Johnson KA, Sperling RA, Marshall GA. Lower Late-Life Body-Mass Index is Associated with Higher Cortical Amyloid Burden in Clinically Normal Elderly. J Alzheimers Dis. 2016 06 18; 53(3):1097-105. PMID: 27340843; PMCID: PMC4976009.
  39. Donovan NJ, Wu Q, Rentz DM, Sperling RA, Marshall GA, Glymour MM. Loneliness, depression and cognitive function in older U.S. adults. Int J Geriatr Psychiatry. 2017 May; 32(5):564-573. PMID: 27162047.
    View in: PubMed
  40. Rentz DM, Dekhtyar M, Sherman J, Burnham S, Blacker D, Aghjayan SL, Papp KV, Amariglio RE, Schembri A, Chenhall T, Maruff P, Aisen P, Hyman BT, Sperling RA. The Feasibility of At-Home iPad Cognitive Testing For Use in Clinical Trials. J Prev Alzheimers Dis. 2016 Mar; 3(1):8-12. PMID: 26998469.
    View in: PubMed
  41. Maye JE, Betensky RA, Gidicsin CM, Locascio J, Becker JA, Pepin L, Carmasin J, Rentz DM, Marshall GA, Blacker D, Sperling RA, Johnson KA. Maternal dementia age at onset in relation to amyloid burden in non-demented elderly offspring. Neurobiol Aging. 2016 Apr; 40:61-67. PMID: 26973104.
    View in: PubMed
  42. Johnson KA, Schultz A, Betensky RA, Becker JA, Sepulcre J, Rentz D, Mormino E, Chhatwal J, Amariglio R, Papp K, Marshall G, Albers M, Mauro S, Pepin L, Alverio J, Judge K, Philiossaint M, Shoup T, Yokell D, Dickerson B, Gomez-Isla T, Hyman B, Vasdev N, Sperling R. Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann Neurol. 2016 Jan; 79(1):110-9. PMID: 26505746; PMCID: PMC4738026 [Available on 01/01/17].
  43. Marshall GA, Dekhtyar M, Bruno JM, Jethwani K, Amariglio RE, Johnson KA, Sperling RA, Rentz DM. The Harvard Automated Phone Task: new performance-based activities of daily living tests for early Alzheimer's disease. J Prev Alzheimers Dis. 2015 Dec; 2(4):242-253. PMID: 26665121.
    View in: PubMed
  44. Wessels AM, Siemers ER, Yu P, Andersen SW, Holdridge KC, Sims JR, Sundell K, Stern Y, Rentz DM, Dubois B, Jones RW, Cummings J, Aisen PS. A Combined Measure of Cognition and Function for Clinical Trials: The Integrated Alzheimer's Disease Rating Scale (iADRS). J Prev Alzheimers Dis. 2015 Dec 01; 2(4):227-241. PMID: 27019841.
    View in: PubMed
  45. Papp KV, Mormino EC, Amariglio RE, Munro C, Dagley A, Schultz AP, Johnson KA, Sperling RA, Rentz DM. Biomarker validation of a decline in semantic processing in preclinical Alzheimer's disease. Neuropsychology. 2016 07; 30(5):624-30. PMID: 26595826; PMCID: PMC4877295 [Available on 07/01/17].
  46. Malone JC, Liu SR, Vaillant GE, Rentz DM, Waldinger RJ. Midlife Eriksonian psychosocial development: Setting the stage for late-life cognitive and emotional health. Dev Psychol. 2016 Mar; 52(3):496-508. PMID: 26551530.
    View in: PubMed
  47. Rabin LA, Smart CM, Crane PK, Amariglio RE, Berman LM, Boada M, Buckley RF, Chételat G, Dubois B, Ellis KA, Gifford KA, Jefferson AL, Jessen F, Katz MJ, Lipton RB, Luck T, Maruff P, Mielke MM, Molinuevo JL, Naeem F, Perrotin A, Petersen RC, Rami L, Reisberg B, Rentz DM, Riedel-Heller SG, Risacher SL, Rodriguez O, Sachdev PS, Saykin AJ, Slavin MJ, Snitz BE, Sperling RA, Tandetnik C, van der Flier WM, Wagner M, Wolfsgruber S, Sikkes SA. Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies. J Alzheimers Dis. 2015 Sep 24; 48 Suppl 1:S63-86. PMID: 26402085.
    View in: PubMed
  48. Alegret M, Valero S, Ortega G, Espinosa A, Sanabria A, Hernández I, Rodríguez O, Rosende-Roca M, Mauleón A, Vargas L, Martín E, Ruíz A, Tárraga L, Amariglio RE, Rentz DM, Boada M. Validation of the Spanish Version of the Face Name Associative Memory Exam (S-FNAME) in Cognitively Normal Older Individuals. Arch Clin Neuropsychol. 2015 Nov; 30(7):712-20. PMID: 26289054; PMCID: PMC4751234 [Available on 11/01/16].
  49. Gidicsin CM, Maye JE, Locascio JJ, Pepin LC, Philiossaint M, Becker JA, Younger AP, Dekhtyar M, Schultz AP, Amariglio RE, Marshall GA, Rentz DM, Hedden T, Sperling RA, Johnson KA. Cognitive activity relates to cognitive performance but not to Alzheimer disease biomarkers. Neurology. 2015 Jul 07; 85(1):48-55. PMID: 26062627; PMCID: PMC4501938.
  50. Amariglio RE, Mormino EC, Pietras AC, Marshall GA, Vannini P, Johnson KA, Sperling RA, Rentz DM. Subjective cognitive concerns, amyloid-ß, and neurodegeneration in clinically normal elderly. Neurology. 2015 Jul 07; 85(1):56-62. PMID: 26048028; PMCID: PMC4501939.
  51. Sperling RA, Amariglio RE, Marshall GA, Rentz DM. Establishing Clinical Relevance in Preclinical Alzheimer's Disease. J Prev Alzheimers Dis. 2015 Jun; 2(2):85-87. PMID: 26247003.
    View in: PubMed
  52. Papp KV, Amariglio RE, Mormino EC, Hedden T, Dekhytar M, Johnson KA, Sperling RA, Rentz DM. Free and cued memory in relation to biomarker-defined abnormalities in clinically normal older adults and those at risk for Alzheimer's disease. Neuropsychologia. 2015 Jul; 73:169-75. PMID: 26002757; PMCID: PMC4479270.
  53. Growdon ME, Schultz AP, Dagley AS, Amariglio RE, Hedden T, Rentz DM, Johnson KA, Sperling RA, Albers MW, Marshall GA. Odor identification and Alzheimer disease biomarkers in clinically normal elderly. Neurology. 2015 May 26; 84(21):2153-60. PMID: 25934852.
    View in: PubMed
  54. Dagley A, LaPoint M, Huijbers W, Hedden T, McLaren DG, Chatwal JP, Papp KV, Amariglio RE, Blacker D, Rentz DM, Johnson KA, Sperling RA, Schultz AP. Harvard Aging Brain Study: Dataset and accessibility. Neuroimage. 2017 01; 144(Pt B):255-258. PMID: 25843019.
    View in: PubMed
  55. Amariglio RE, Donohue MC, Marshall GA, Rentz DM, Salmon DP, Ferris SH, Karantzoulis S, Aisen PS, Sperling RA. Tracking early decline in cognitive function in older individuals at risk for Alzheimer disease dementia: the Alzheimer's Disease Cooperative Study Cognitive Function Instrument. JAMA Neurol. 2015 Apr; 72(4):446-54. PMID: 25706191; PMCID: PMC4397164.
  56. Huijbers W, Mormino EC, Schultz AP, Wigman S, Ward AM, Larvie M, Amariglio RE, Marshall GA, Rentz DM, Johnson KA, Sperling RA. Amyloid-ß deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression. Brain. 2015 Apr; 138(Pt 4):1023-35. PMID: 25678559; PMCID: PMC4438387.
  57. Kahle-Wrobleski K, Andrews JS, Belger M, Gauthier S, Stern Y, Rentz DM, Galasko D. Clinical and Economic Characteristics of Milestones along the Continuum of Alzheimer's Disease: Transforming Functional Scores into Levels of Dependence. J Prev Alzheimers Dis. 2015; 2(2):115-120. PMID: 28775969.
    View in: PubMed
  58. Alegret M, Rodríguez O, Espinosa A, Ortega G, Sanabria A, Valero S, Hernández I, Rosende-Roca M, Vargas L, Abdelnour C, Mauleón A, Gailhajanet A, Martín E, Tárraga L, Rentz DM, Amariglio RE, Ruíz A, Boada M. Concordance between Subjective and Objective Memory Impairment in Volunteer Subjects. J Alzheimers Dis. 2015; 48(4):1109-17. PMID: 26444795.
    View in: PubMed
  59. Lorius N, Locascio JJ, Rentz DM, Johnson KA, Sperling RA, Viswanathan A, Marshall GA. Vascular disease and risk factors are associated with cognitive decline in the alzheimer disease spectrum. Alzheimer Dis Assoc Disord. 2015 Jan-Mar; 29(1):18-25. PMID: 24787033; PMCID: PMC4366000.
  60. Marshall GA, Zoller AS, Lorius N, Amariglio RE, Locascio JJ, Johnson KA, Sperling RA, Rentz DM. Functional Activities Questionnaire Items that Best Discriminate and Predict Progression from Clinically Normal to Mild Cognitive Impairment. Curr Alzheimer Res. 2015; 12(5):493-502. PMID: 26017560; PMCID: PMC4448081.
  61. Munro CE, Donovan NJ, Guercio BJ, Wigman SE, Schultz AP, Amariglio RE, Rentz DM, Johnson KA, Sperling RA, Marshall GA. Neuropsychiatric Symptoms and Functional Connectivity in Mild Cognitive Impairment. J Alzheimers Dis. 2015; 46(3):727-35. PMID: 25854929; PMCID: PMC4583318.
  62. Donovan NJ, Hsu DC, Dagley AS, Schultz AP, Amariglio RE, Mormino EC, Okereke OI, Rentz DM, Johnson KA, Sperling RA, Marshall GA. Depressive Symptoms and Biomarkers of Alzheimer's Disease in Cognitively Normal Older Adults. J Alzheimers Dis. 2015; 46(1):63-73. PMID: 25697700; PMCID: PMC4544638.
  63. Guercio BJ, Donovan NJ, Munro CE, Aghjayan SL, Wigman SE, Locascio JJ, Amariglio RE, Rentz DM, Johnson KA, Sperling RA, Marshall GA. The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment. J Alzheimers Dis. 2015; 47(2):421-32. PMID: 26401564; PMCID: PMC4602169.
  64. Guercio BJ, Donovan NJ, Ward A, Schultz A, Lorius N, Amariglio RE, Rentz DM, Johnson KA, Sperling RA, Marshall GA. Apathy is associated with lower inferior temporal cortical thickness in mild cognitive impairment and normal elderly individuals. J Neuropsychiatry Clin Neurosci. 2015; 27(1):e22-7. PMID: 25716491; PMCID: PMC4342844.
  65. Mormino EC, Betensky RA, Hedden T, Schultz AP, Amariglio RE, Rentz DM, Johnson KA, Sperling RA. Synergistic effect of ß-amyloid and neurodegeneration on cognitive decline in clinically normal individuals. JAMA Neurol. 2014 Nov; 71(11):1379-85. PMID: 25222039; PMCID: PMC4293023.
  66. Samieri C, Proust-Lima C, M Glymour M, Okereke OI, Amariglio RE, Sperling RA, Rentz DM, Grodstein F. Subjective cognitive concerns, episodic memory, and the APOE e4 allele. Alzheimers Dement. 2014 Nov; 10(6):752-759.e1. PMID: 25256133.
    View in: PubMed
  67. Marquie M, Locascio JJ, Rentz DM, Becker JA, Hedden T, Johnson KA, Growdon JH, Gomperts SN. Striatal and extrastriatal dopamine transporter levels relate to cognition in Lewy body diseases: an (11)C altropane positron emission tomography study. Alzheimers Res Ther. 2014; 6(5-8):52. PMID: 25429309; PMCID: PMC4245149.
  68. Donohue MC, Sperling RA, Salmon DP, Rentz DM, Raman R, Thomas RG, Weiner M, Aisen PS. The preclinical Alzheimer cognitive composite: measuring amyloid-related decline. JAMA Neurol. 2014 Aug; 71(8):961-70. PMID: 24886908; PMCID: PMC4439182.
  69. Zhuravleva TY, Alperin BR, Haring AE, Rentz DM, Holcomb PJ, Daffner KR. Age-related decline in bottom-up processing and selective attention in the very old. J Clin Neurophysiol. 2014 Jun; 31(3):261-71. PMID: 24887611; PMCID: PMC4048878.
  70. Papp KV, Amariglio RE, Dekhtyar M, Roy K, Wigman S, Bamfo R, Sherman J, Sperling RA, Rentz DM. Development of a psychometrically equivalent short form of the Face-Name Associative Memory Exam for use along the early Alzheimer's disease trajectory. Clin Neuropsychol. 2014; 28(5):771-85. PMID: 24815535.
    View in: PubMed
  71. Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Chételat G, Dubois B, Dufouil C, Ellis KA, van der Flier WM, Glodzik L, van Harten AC, de Leon MJ, McHugh P, Mielke MM, Molinuevo JL, Mosconi L, Osorio RS, Perrotin A, Petersen RC, Rabin LA, Rami L, Reisberg B, Rentz DM, Sachdev PS, de la Sayette V, Saykin AJ, Scheltens P, Shulman MB, Slavin MJ, Sperling RA, Stewart R, Uspenskaya O, Vellas B, Visser PJ, Wagner M. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimers Dement. 2014 Nov; 10(6):844-52. PMID: 24798886.
    View in: PubMed
  72. Mormino EC, Betensky RA, Hedden T, Schultz AP, Ward A, Huijbers W, Rentz DM, Johnson KA, Sperling RA. Amyloid and APOE e4 interact to influence short-term decline in preclinical Alzheimer disease. Neurology. 2014 May 20; 82(20):1760-7. PMID: 24748674.
    View in: PubMed
  73. Alperin BR, Mott KK, Rentz DM, Holcomb PJ, Daffner KR. Investigating the age-related "anterior shift" in the scalp distribution of the P3b component using principal component analysis. Psychophysiology. 2014 Jul; 51(7):620-33. PMID: 24660980; PMCID: PMC4630002.
  74. Sperling RA, Rentz DM, Johnson KA, Karlawish J, Donohue M, Salmon DP, Aisen P. The A4 study: stopping AD before symptoms begin? Sci Transl Med. 2014 Mar 19; 6(228):228fs13. PMID: 24648338.
    View in: PubMed
  75. Donovan NJ, Amariglio RE, Zoller AS, Rudel RK, Gomez-Isla T, Blacker D, Hyman BT, Locascio JJ, Johnson KA, Sperling RA, Marshall GA, Rentz DM. Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer disease. Am J Geriatr Psychiatry. 2014 Dec; 22(12):1642-51. PMID: 24698445; PMCID: PMC4145054.
  76. Harrison J, Rentz DM, McLaughlin T, Niecko T, Gregg KM, Black RS, Buchanan J, Liu E, Grundman M. Cognition in MCI and Alzheimer's disease: baseline data from a longitudinal study of the NTB. Clin Neuropsychol. 2014; 28(2):252-68. PMID: 24521259.
    View in: PubMed
  77. Zoller AS, Gaal IM, Royer CA, Locascio JJ, Amariglio RE, Blacker D, Okereke OI, Johnson KA, Sperling RA, Rentz DM, Marshall GA. SIST-M-IR activities of daily living items that best discriminate clinically normal elderly from those with mild cognitive impairment. Curr Alzheimer Res. 2014; 11(8):785-91. PMID: 25212917; PMCID: PMC4163929.
  78. Marshall GA, Lorius N, Locascio JJ, Hyman BT, Rentz DM, Johnson KA, Sperling RA. Regional cortical thinning and cerebrospinal biomarkers predict worsening daily functioning across the Alzheimer's disease spectrum. J Alzheimers Dis. 2014; 41(3):719-28. PMID: 24685624; PMCID: PMC4111766.
  79. Roy K, Pepin LC, Philiossaint M, Lorius N, Becker JA, Locascio JJ, Rentz DM, Sperling RA, Johnson KA, Marshall GA. Regional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer's disease spectrum. J Alzheimers Dis. 2014; 42(1):291-300. PMID: 24898635; PMCID: PMC4133312.
  80. Marshall GA, Zoller AS, Kelly KE, Amariglio RE, Locascio JJ, Johnson KA, Sperling RA, Rentz DM. Everyday cognition scale items that best discriminate between and predict progression from clinically normal to mild cognitive impairment. Curr Alzheimer Res. 2014; 11(9):853-61. PMID: 25274110; PMCID: PMC4247808.
  81. Rentz DM, Parra Rodriguez MA, Amariglio R, Stern Y, Sperling R, Ferris S. Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer's disease: a selective review. Alzheimers Res Ther. 2013; 5(6):58. PMID: 24257331.
    View in: PubMed
  82. Alperin BR, Haring AE, Zhuravleva TY, Holcomb PJ, Rentz DM, Daffner KR. The dissociation between early and late selection in older adults. J Cogn Neurosci. 2013 Dec; 25(12):2189-206. PMID: 23915054; PMCID: PMC4642708.
  83. Donovan NJ, Wadsworth LP, Lorius N, Locascio JJ, Rentz DM, Johnson KA, Sperling RA, Marshall GA. Regional cortical thinning predicts worsening apathy and hallucinations across the Alzheimer disease spectrum. Am J Geriatr Psychiatry. 2014 Nov; 22(11):1168-79. PMID: 23890751; PMCID: PMC3960369.
  84. Roe CM, Rentz DM. Alzheimer disease: before the diagnosis. Neurology. 2013 Mar 26; 80(13):e148-9. PMID: 23530160.
    View in: PubMed
  85. Jicha GA, Rentz DM. Cognitive and brain reserve and the diagnosis and treatment of preclinical Alzheimer disease. Neurology. 2013 Mar 26; 80(13):1180-1. PMID: 23486882.
    View in: PubMed
  86. Haring AE, Zhuravleva TY, Alperin BR, Rentz DM, Holcomb PJ, Daffner KR. Age-related differences in enhancement and suppression of neural activity underlying selective attention in matched young and old adults. Brain Res. 2013 Mar 07; 1499:69-79. PMID: 23313874; PMCID: PMC3570693.
  87. Marshall GA, Donovan NJ, Lorius N, Gidicsin CM, Maye J, Pepin LC, Becker JA, Amariglio RE, Rentz DM, Sperling RA, Johnson KA. Apathy is associated with increased amyloid burden in mild cognitive impairment. J Neuropsychiatry Clin Neurosci. 2013; 25(4):302-7. PMID: 24247857; PMCID: PMC3957217.
  88. Gomperts SN, Locascio JJ, Rentz D, Santarlasci A, Marquie M, Johnson KA, Growdon JH. Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia. Neurology. 2013 Jan 01; 80(1):85-91. PMID: 23243071; PMCID: PMC3589197.
  89. Hedden T, Mormino EC, Amariglio RE, Younger AP, Schultz AP, Becker JA, Buckner RL, Johnson KA, Sperling RA, Rentz DM. Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults. J Neurosci. 2012 Nov 14; 32(46):16233-42. PMID: 23152607; PMCID: PMC3523110.
  90. Marshall GA, Amariglio RE, Sperling RA, Rentz DM. Activities of daily living: where do they fit in the diagnosis of Alzheimer's disease? Neurodegener Dis Manag. 2012 Oct 01; 2(5):483-491. PMID: 23585777.
    View in: PubMed
  91. Wadsworth LP, Lorius N, Donovan NJ, Locascio JJ, Rentz DM, Johnson KA, Sperling RA, Marshall GA. Neuropsychiatric symptoms and global functional impairment along the Alzheimer's continuum. Dement Geriatr Cogn Disord. 2012; 34(2):96-111. PMID: 22922821; PMCID: PMC3549662.
  92. Amariglio RE, Becker JA, Carmasin J, Wadsworth LP, Lorius N, Sullivan C, Maye JE, Gidicsin C, Pepin LC, Sperling RA, Johnson KA, Rentz DM. Subjective cognitive complaints and amyloid burden in cognitively normal older individuals. Neuropsychologia. 2012 Oct; 50(12):2880-6. PMID: 22940426; PMCID: PMC3473106.
  93. Daffner KR, Tarbi EC, Haring AE, Zhuravleva TY, Sun X, Rentz DM, Holcomb PJ. The influence of executive capacity on selective attention and subsequent processing. Front Hum Neurosci. 2012; 6:167. PMID: 22701415; PMCID: PMC3373205.
  94. Gomperts SN, Locascio JJ, Marquie M, Santarlasci AL, Rentz DM, Maye J, Johnson KA, Growdon JH. Brain amyloid and cognition in Lewy body diseases. Mov Disord. 2012 Jul; 27(8):965-73. PMID: 22693110; PMCID: PMC3725259.
  95. McLaren DG, Sreenivasan A, Diamond EL, Mitchell MB, Van Dijk KR, Deluca AN, O'Brien JL, Rentz DM, Sperling RA, Atri A. Tracking cognitive change over 24 weeks with longitudinal functional magnetic resonance imaging in Alzheimer's disease. Neurodegener Dis. 2012; 9(4):176-86. PMID: 22456451; PMCID: PMC3369254.
  96. Amariglio RE, Frishe K, Olson LE, Wadsworth LP, Lorius N, Sperling RA, Rentz DM. Validation of the Face Name Associative Memory Exam in cognitively normal older individuals. J Clin Exp Neuropsychol. 2012; 34(6):580-7. PMID: 22765048; PMCID: PMC3391747.
  97. Daffner KR, Zhuravleva TY, Sun X, Tarbi EC, Haring AE, Rentz DM, Holcomb PJ. Does modulation of selective attention to features reflect enhancement or suppression of neural activity? Biol Psychol. 2012 Feb; 89(2):398-407. PMID: 22178708; PMCID: PMC3272645.
  98. Putcha D, Brickhouse M, O'Keefe K, Sullivan C, Rentz D, Marshall G, Dickerson B, Sperling R. Hippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults. J Neurosci. 2011 Nov 30; 31(48):17680-8. PMID: 22131428; PMCID: PMC3289551.
  99. Amariglio RE, Townsend MK, Grodstein F, Sperling RA, Rentz DM. Specific subjective memory complaints in older persons may indicate poor cognitive function. J Am Geriatr Soc. 2011 Sep; 59(9):1612-7. PMID: 21919893; PMCID: PMC3315361.
  100. Jefferson AL, Gibbons LE, Rentz DM, Carvalho JO, Manly J, Bennett DA, Jones RN. A life course model of cognitive activities, socioeconomic status, education, reading ability, and cognition. J Am Geriatr Soc. 2011 Aug; 59(8):1403-11. PMID: 21797830; PMCID: PMC3222272.
  101. Marshall GA, Olson LE, Frey MT, Maye J, Becker JA, Rentz DM, Sperling RA, Johnson KA. Instrumental activities of daily living impairment is associated with increased amyloid burden. Dement Geriatr Cogn Disord. 2011; 31(6):443-50. PMID: 21778725.
    View in: PubMed
  102. Jones RN, Manly J, Glymour MM, Rentz DM, Jefferson AL, Stern Y. Conceptual and measurement challenges in research on cognitive reserve. J Int Neuropsychol Soc. 2011 Jul; 17(4):593-601. PMID: 21411036; PMCID: PMC3289742.
  103. Rentz DM, Amariglio RE, Becker JA, Frey M, Olson LE, Frishe K, Carmasin J, Maye JE, Johnson KA, Sperling RA. Face-name associative memory performance is related to amyloid burden in normal elderly. Neuropsychologia. 2011 Jul; 49(9):2776-83. PMID: 21689670; PMCID: PMC3137730.
  104. Atri A, O'Brien JL, Sreenivasan A, Rastegar S, Salisbury S, DeLuca AN, O'Keefe KM, LaViolette PS, Rentz DM, Locascio JJ, Sperling RA. Test-retest reliability of memory task functional magnetic resonance imaging in Alzheimer disease clinical trials. Arch Neurol. 2011 May; 68(5):599-606. PMID: 21555634; PMCID: PMC3291175.
  105. Marshall GA, Rentz DM, Frey MT, Locascio JJ, Johnson KA, Sperling RA. Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer's disease. Alzheimers Dement. 2011 May; 7(3):300-8. PMID: 21575871; PMCID: PMC3096844.
  106. Becker JA, Hedden T, Carmasin J, Maye J, Rentz DM, Putcha D, Fischl B, Greve DN, Marshall GA, Salloway S, Marks D, Buckner RL, Sperling RA, Johnson KA. Amyloid-ß associated cortical thinning in clinically normal elderly. Ann Neurol. 2011 Jun; 69(6):1032-42. PMID: 21437929; PMCID: PMC3117980.
  107. Vannini P, Hedden T, Becker JA, Sullivan C, Putcha D, Rentz D, Johnson KA, Sperling RA. Age and amyloid-related alterations in default network habituation to stimulus repetition. Neurobiol Aging. 2012 Jul; 33(7):1237-52. PMID: 21334099; PMCID: PMC3111876.
  108. Putcha D, O'Keefe K, LaViolette P, O'Brien J, Greve D, Rentz DM, Locascio J, Atri A, Sperling R. Reliability of functional magnetic resonance imaging associative encoding memory paradigms in non-demented elderly adults. Hum Brain Mapp. 2011 Dec; 32(12):2027-44. PMID: 21259385; PMCID: PMC3551453.
  109. Daffner KR, Sun X, Tarbi EC, Rentz DM, Holcomb PJ, Riis JL. Does compensatory neural activity survive old-old age? Neuroimage. 2011 Jan 01; 54(1):427-38. PMID: 20696255; PMCID: PMC2962703.
  110. Wolk DA, Dickerson BC. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease. Proc Natl Acad Sci U S A. 2010 Jun 01; 107(22):10256-61. PMID: 20479234; PMCID: PMC2890481.
  111. Rentz DM, Locascio JJ, Becker JA, Moran EK, Eng E, Buckner RL, Sperling RA, Johnson KA. Cognition, reserve, and amyloid deposition in normal aging. Ann Neurol. 2010 Mar; 67(3):353-64. PMID: 20373347.
    View in: PubMed
  112. Sperling RA, Dickerson BC, Pihlajamaki M, Vannini P, LaViolette PS, Vitolo OV, Hedden T, Becker JA, Rentz DM, Selkoe DJ, Johnson KA. Functional alterations in memory networks in early Alzheimer's disease. Neuromolecular Med. 2010 Mar; 12(1):27-43. PMID: 20069392.
    View in: PubMed
  113. Sperling RA, Laviolette PS, O'Keefe K, O'Brien J, Rentz DM, Pihlajamaki M, Marshall G, Hyman BT, Selkoe DJ, Hedden T, Buckner RL, Becker JA, Johnson KA. Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron. 2009 Jul 30; 63(2):178-88. PMID: 19640477; PMCID: PMC2738994.
  114. Riis JL, Chong H, McGinnnis S, Tarbi E, Sun X, Holcomb PJ, Rentz DM, Daffner KR. Age-related changes in early novelty processing as measured by ERPs. Biol Psychol. 2009 Sep; 82(1):33-44. PMID: 19463888; PMCID: PMC2775712.
  115. Gomperts SN, Rentz DM, Moran E, Becker JA, Locascio JJ, Klunk WE, Mathis CA, Elmaleh DR, Shoup T, Fischman AJ, Hyman BT, Growdon JH, Johnson KA. Imaging amyloid deposition in Lewy body diseases. Neurology. 2008 Sep 16; 71(12):903-10. PMID: 18794492; PMCID: PMC2637553.
  116. Miller SL, Celone K, DePeau K, Diamond E, Dickerson BC, Rentz D, Pihlajamäki M, Sperling RA. Age-related memory impairment associated with loss of parietal deactivation but preserved hippocampal activation. Proc Natl Acad Sci U S A. 2008 Feb 12; 105(6):2181-6. PMID: 18238903; PMCID: PMC2538895.
  117. Diamond EL, Miller S, Dickerson BC, Atri A, DePeau K, Fenstermacher E, Pihlajamäki M, Celone K, Salisbury S, Gregas M, Rentz D, Sperling RA. Relationship of fMRI activation to clinical trial memory measures in Alzheimer disease. Neurology. 2007 Sep 25; 69(13):1331-41. PMID: 17893294.
    View in: PubMed
  118. Dorene M. Rentz, Terri J. Huh, Lisa M. Sardinha, Erin K. Moran,John A. Becker, Kirk R. Daffner, Reisa A. Sperling, Keith A. Johnson . Intelligent quotient-adjusted memory impairment is associated with abnormal Single Photo Emission Computed Tomography Perfusion. Journal of the International Neuropsychological Society. 2007; 13 (5):821-831.
  119. Johnson KA, Gregas M, Becker JA, Kinnecom C, Salat DH, Moran EK, Smith EE, Rosand J, Rentz DM, Klunk WE, Mathis CA, Price JC, Dekosky ST, Fischman AJ, Greenberg SM. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol. 2007 Sep; 62(3):229-34. PMID: 17683091.
    View in: PubMed
  120. Rentz DM, Huh TJ, Sardinha LM, Moran EK, Becker JA, Daffner KR, Sperling RA, Johnson KA. Intelligence quotient-adjusted memory impairment is associated with abnormal single photon emission computed tomography perfusion. J Int Neuropsychol Soc. 2007 Sep; 13(5):821-31. PMID: 17697413.
    View in: PubMed
  121. Riis JL, Chong H, Ryan KK, Wolk DA, Rentz DM, Holcomb PJ, Daffner KR. Compensatory neural activity distinguishes different patterns of normal cognitive aging. Neuroimage. 2008 Jan 01; 39(1):441-54. PMID: 17931892; PMCID: PMC2219544.
  122. Klunk WE, Price JC, Mathis CA, Tsopelas ND, Lopresti BJ, Ziolko SK, Bi W, Hoge JA, Cohen AD, Ikonomovic MD, Saxton JA, Snitz BE, Pollen DA, Moonis M, Lippa CF, Swearer JM, Johnson KA, Rentz DM, Fischman AJ, Aizenstein HJ, DeKosky ST. Amyloid Deposition Begins in the Striatum of Presenilin-1 Mutation Carriers from Two Unrelated Pedigrees. Journal of Neuroscience. 2007; 27(23):6174-6184.
  123. Klunk WE, Price JC, Mathis CA, Tsopelas ND, Lopresti BJ, Ziolko SK, Bi W, Hoge JA, Cohen AD, Ikonomovic MD, Saxton JA, Snitz BE, Pollen DA, Moonis M, Lippa CF, Swearer JM, Johnson KA, Rentz DM, Fischman AJ, Aizenstein HJ, DeKosky ST. Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci. 2007 Jun 06; 27(23):6174-84. PMID: 17553989; PMCID: PMC3265970.
  124. Daffner KR, Chong H, Riis J, Rentz DM, Wolk DA, Budson AE, Holcomb PJ. Cognitive status impacts age-related changes in attention to novel and target events in normal adults. Neuropsychology. 2007 May; 21(3):291-300. PMID: 17484592; PMCID: PMC3045751.
  125. Rentz D, Moran E, Eng E, Becker J, Mathis C, Klunk W, Sperling R, Fischman A, Johnson K. Cognitive Follow-up in Non-Demented Subjects with Evidence of Amyloid Deposition Using Pittsburgh Compound-B (PIB)(Platform Presentation). Neurology, Boston. 2007; 68(Suppl to Neurology):A328.
  126. Rentz D.M., Moran E., Eng E., Becker J.A., Mathis C.A., Klunk W.E., Sperling R.A., Fischman A.J., Johnson K.A. Cognitive follow-up in non-demented subjects with evidence of amyloid deposition using Pittsburg Compound-B (PIB). Twentieth Annual ADRC Scientific Symposium. 2007; 19.
  127. Sperling R, Laviolette P, White E, Gregas M, Moran E, Rentz D,Becker JA, Klunk W, Price J, Matthis C, Fischman A, Selkoe D, Johnson K. . Neocortical Amyloid Deposition Associated with Decreased Medial Temporal Lobe fMRI Activation. (Platform Presentation). Neurology. 2007; 68((Suppl 1)):A329.
  128. Rentz DM, Sardinha LM, Huh TJ, Searl MM, Daffner KR, Sperling RA. IQ-based norms for highly intelligent adults. Clin Neuropsychol. 2006 Dec; 20(4):637-48. PMID: 16980251.
    View in: PubMed
  129. Celone KA, Calhoun VD, Dickerson BC, Atri A, Chua EF, Miller SL, DePeau K, Rentz DM, Selkoe DJ, Blacker D, Albert MS, Sperling RA. Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis. J Neurosci. 2006 Oct 04; 26(40):10222-31. PMID: 17021177.
    View in: PubMed
  130. Daffner KR, Ryan KK, Williams DM, Budson AE, Rentz DM, Wolk DA, Holcomb PJ. Increased responsiveness to novelty is associated with successful cognitive aging. J Cogn Neurosci. 2006 Oct; 18(10):1759-73. PMID: 17014379.
    View in: PubMed
  131. Rentz DM, Sardinha LM, Manning LN, Moran EK, Becker JA, Gregas M, Sperling RA, DeKosky ST, Mathis CA, Klunk WE, Fischman AJ, Johnson KJ . Amyloid burden correlates with cognitive function in normal aging MCI and AD . Alzheimer's & Dementia, 10th International Conference on Alzheimer's Disease, Madrid Spain. 2006; 2(3):S337.
  132. Greenberg SM, Kinnecom K, Klunk WE, Mathis CA, DeKosky ST, Price JC, Rentz DM, Moran EK, Fischman AJ, Johnson KA . Imaging of cerebral amyloid angiopathy with Pittsburgh Compound-B (Platform Presentation) . Alzheimer's and Dementia, 10th Int Conf on Alzheimer's Disease and Related Disorders, Madrid, Spain . 2006; 2(3):S337.
  133. Johnson K.A., Rentz D., Moran E.K., Becker J.A., Sperling R., Pollen D., Moonis M., Swearer J., Hyman B., Selkoe D., DeKosky S., athis C.A., Klunk W.E., Fischman A.J. Amyloid Imaging in Presymptomatic and Symtomatic Familial Alzheimer's Disease. Supplement to Neurology, San Diego. 2006; 66(5):A102.
  134. Johnson KA, Pollen D, Rentz D, Moran EK, Becker JA, Moonis M, Swearer J, Hyman B, Selkoe D, Sperling R, DeKosky S, Mathis C, Klunk W, Fischman A . Amyloid deposition in presymptomatic familial Alzheimer's disease . Alzheimer's & Dementia, 10th Int Conf on Alzheimer's Disease and Related Disorders, Madrid, Spain . 2006.
  135. Rentz DM, Becker JA, Moran EK, Sardinha LM, Manning LN, Shoup TM, Mathis CM, DeKosky ST, Klunk WE, Sperling RA, Fischman AJ, Johnson KA . Amyloid imaging with Pittsburgh Compound-B (PIB) in AD, MCI, and highly intelligent older adults (Platform Presentation). Supplement to Neurology, San Diego. 2006; 66(5):A181.
  136. Johnson KA, Rentz D, Moran E, Becker JA, Pollen D, Shoup TM, Selkoe D, Mathis C, Klunk W, Fischman AJ . Amyloid imaging with Pittsburgh Compound-B in presymptomatic familial Alzheimer's disease . Society of Nuclear Medicine, San Diego, . 2006; 66(5):A102.
  137. Diamond E.L., Atri A., DePeau K., Miller S., Celone K., Pihlajamaki M., Dickerson B.C., Sardinha L., Salisbury S., Rentz, D., Sperling R. Relationship of Functional MRI Activation to Standarized Clinical Trial Measures in AD. Supplement to Neurology, San Diego. 2006; 66(5):A103.
  138. Daffner KR, Ryan KK, Williams DM, Budson AE, Rentz DM, Wolk DA, Holcomb PJ. Age-related differences in attention to novelty among cognitively high performing adults. Biol Psychol. 2006 Apr; 72(1):67-77. PMID: 16198046.
    View in: PubMed
  139. Dickerson BC, Salat DH, Greve DN, Chua EF, Rand-Giovannetti E, Rentz DM, Bertram L, Mullin K, Tanzi RE, Blacker D, Albert MS, Sperling RA. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology. 2005 Aug 09; 65(3):404-11. PMID: 16087905; PMCID: PMC4335677.
  140. Daffner KR, Ryan KK, Williams DM, Budson AE, Rentz DM, Scinto LFM, Holcomb PJ. Age-sensitivity of the P3 in cognitively high performing adults: Unsettled issues. Neurobiology of Aging. 2005; 26:1301-1304.
  141. Daffner KR, Ryan KK, Williams DM, Budson AE, Rentz DM, Scinto LF, Holcomb PJ. Age-related differences in novelty and target processing among cognitively high performing adults. Neurobiol Aging. 2005 Oct; 26(9):1283-95. PMID: 16054727.
    View in: PubMed
  142. Johnson KA, Rentz DM, Moran EK, Becker JA, Schlossmacher MG, Sudarsky LR, Fischman AJ. Combined Dopamine Transporter and FDG PET in DLB, AD, and PD. 9th International Conference on Alzheimer's Disease and Related Disorders, Washington, D.C. 2004.
  143. Rentz DM, Huh TJ, Faust RR, Budson AE, Scinto LF, Sperling RA, Daffner KR. Use of IQ-adjusted norms to predict progressive cognitive decline in highly intelligent older individuals. Neuropsychology. 2004 Jan; 18(1):38-49. PMID: 14744186.
    View in: PubMed
  144. Johnson KA, Rentz DM, Moran EK, Becker JA, Schlossmacher MG, Sudarsky LR, Fischman AJ. Combined dopamine transporter and FDG PET in DLB, AD, and PD. American Academy of Neurology, Annual Meeting, San Francisco, CA. 2004.
  145. Johnson KA, Rentz DM, Moran EK, Schlossmacher MG, Sudarsky LR, Becker JA, Fischman AJ. Dopamine Transporter and FDG PET In Dementia With Lewy Bodies, Alzheimers Disease, And Parkinsons Disease. Society of Nuclear Medicine Annual Meeting, Phladelphia, PA. 2004.
  146. Johnson KA, Rentz DM, Moran EK, Becker JA, Schlossmacher MG, Sudarsky LR, Fischman AJ. Dopamine Transporter And FDG PET in Dementia with Lewy Bodies, Alzheimer’s Disease, and Parkinson’s Disease. Organization of Human Brain Mapping, Annual Meeting, Budapest, Hungary. 2004.
  147. Budson AE, Michalska KJ, Sullivan AL, Rentz DM, Daffner KR, Schacter DL. False recognition in Alzheimer disease: evidence from categorized pictures. Cogn Behav Neurol. 2003 Mar; 16(1):16-27. PMID: 14764998.
    View in: PubMed
  148. Daffner KR, Scinto LF, Weitzman AM, Faust R, Rentz DM, Budson AE, Holcomb PJ. Frontal and parietal components of a cerebral network mediating voluntary attention to novel events. J Cogn Neurosci. 2003 Feb 15; 15(2):294-313. PMID: 12683359.
    View in: PubMed
  149. Rentz, D. Learning Disabilities and Attention Deficit Hyperactivity Disorder In Adulthood. 2003; 912-923.
  150. Sperling RA, Bates JF, Chua EF, Cocchiarella AJ, Rentz DM, Rosen BR, Schacter DL, Albert MS. fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2003 Jan; 74(1):44-50. PMID: 12486265; PMCID: PMC1738201.
  151. Budson AE, Michalska KJ, Rentz DM, Joubert CC, Daffner KR, Schacter DL, Sperling RA. Use of a false recognition paradigm in an Alzheimer's disease clinical trial: a pilot study. Am J Alzheimers Dis Other Demen. 2002 Mar-Apr; 17(2):93-100. PMID: 11954675.
    View in: PubMed
  152. Pickut B, Scinto LFM, Rentz DM, Daffner KR, DeDeyn PP. The pupil assay in fronto temporal and Alzheimer’s dementia. Neurobiology of Aging. 2002; 23:S389.
  153. Budson AE, Michalska KJ, Rentz DM, Joubert CC, Daffner KR, Schacter DL, Sperling RA. Use of a false recognition paradigm in an Alzheimer’s clinical trial: A pilot study. American Journal of Alzheimer’s Disease and Other Dementias. 2002; 17:93-100.
  154. Sperling RA, Chua E, Rentz DM, Bates J, Greve D, Dale A, Rosen B, Albert MS. Functional MRI studies in early Alzheimer’s disease. Neurobiology of Aging. 2002; 23:S562.
  155. Rentz DM, Huh T, Sperling RA, Scinto LFM, Daffner KR. Distinguishing normal from pathological memory declines in highly intelligent elders. Neurobiology of Aging. 2002; 23:S36.
  156. Daffner KR, Rentz DM, Scinto LF, Faust R, Budson AE, Holcomb PJ. Pathophysiology underlying diminished attention to novel events in patients with early AD. Neurology. 2001 May 22; 56(10):1377-83. PMID: 11376191.
    View in: PubMed
  157. Rentz DM, Michalska K, Faust RF, Budson AE, Scinto LFM, Sperling RA, Daffner KR. Predicting Mild Cognitive Impairment (MCI) among highly intelligent elders (Platform Presentation). Neurology. 2001; 56:S09.005.
  158. Glass RJ, Chan G, Rentz D. Cognitive impairment screening in second offense DUI programs. J Subst Abuse Treat. 2000 Dec; 19(4):369-73. PMID: 11166501.
    View in: PubMed
  159. Budson AE, Roth HL, Rentz DM, Ronthal M. Disruption of the ventral visual stream in a case of reduplicative paramnesia. Ann N Y Acad Sci. 2000 Jun; 911:447-52. PMID: 10911890.
    View in: PubMed
  160. Daffner KR, Mesulam MM, Holcomb PJ, Calvo V, Acar D, Chabrerie A, Kikinis R, Jolesz FA, Rentz DM, Scinto LF. Disruption of attention to novel events after frontal lobe injury in humans. J Neurol Neurosurg Psychiatry. 2000 Jan; 68(1):18-24. PMID: 10601395; PMCID: PMC1760636.
  161. Daffner KR, Scinto LFM, Rentz D, Faust R, Zandman D, Holcomb PJ. Age-related changes in the allocation of attention to novel events. Journal of Cognitive Neuroscience. 2000; Suppl(119):C:87.
  162. Sperling R, Cocchiarella A, Bates J, Rentz D, Schacter D, Rpsen B, Albert A. Face-name association fMRI studies. Journal of Cognitive Neuroscience. 2000; Suppl(41):F:137.
  163. Rentz D, Budson A, Michalska K, Daffner KR. Detecting early cognitive decline in high functioning elders. Journal of Cognitive Neuroscience. 2000; Suppl(41):F:137.
  164. Sperling RA, Cocchiarella AJ, Bates JC, Rentz DM, Schacter DL, Rosen BR, Albert MS. Functional MRI studies of face-name association in healthy elderly and mild AD. Neurology. 2000; 54(Suppl 3):A475.
  165. Michalska KJ, Budson AE, Rentz DM, Daffner KR, Schacter DL. Early diagnosis of Alzheimer’s disease using false recognition. Journal of Cognitive Neuroscience. 2000; Suppl(55):F:139.
  166. Rentz D & Weintraub S. Neuropsychological detection of early Alzheimer’s disease. Scinto L & Daffner K, eds. Early Diagnosis of Alzheimer's Disease. 2000; 169-189.
  167. Rentz DM, Daffner KR, Calvo VL, Scinto LFM. Detecting early cognitive decline in high functioning elders. Journal of Geriatric Psychiatry. 2000; 33(1):27-49.
  168. Budson AE, Roth HL, Rentz DM, Ronthal M. Disruption of the Ventral Visual Stream in a Case of Reduplicative Paramnesia. The Parahippocampal Region. 2000; 911:447-452.
  169. Daffner KR, Scinto LFM, Rentz D, Faust R, Zandman D, Holcomb PJ. Age-related changes in the allocation of attention to novel events. Neurology. 2000; 54(Suppl 3):A210.
  170. Scinto LF, Rentz DM, Potter H, Daffner KR. Pupil assay and Alzheimer's disease: a critical analysis. Neurology. 1999 Feb; 52(3):673-4. PMID: 10025819.
    View in: PubMed
  171. Rentz D, Calvo V, Daffner K, Sperling RA, Scinto LFM. Impaired awareness of memory deficits in non-depressed highly intelligent elders. J. Int. Neuropsychol. Soc. 1999; 5:93.
  172. Rentz D, Calvo V, Scinto LFM, Daffner KR. Identifying early cognitive decline in highly intelligent elders: Preliminary data from three year longitudinal follow-up (Platform Presentation). Neurology. 1999; 52:A386.
  173. Sperling R, Johnson K, Dickey C, Fraone S, Rentz D, Jones K, Albert M, Kikinis R, Jolesz F, Scinto L, Selkoe D, Daffner K. Quantitative perfusion SPECT and volumetric MRI in the early diagnosis of AD. Neurobiology of Aging. 1998; S159.
  174. Sperling RA, Jones KJ, Rentz DM, Albert MS, Holman BL, Becker JA, Scinto LFM, Daffner KR, Johnson KA. SPECT cerebral perfusion and apolipoprotein E genotype. Neurology. 1998; 50:A438-439.
  175. Scinto LFM, Spillane A, Rentz D, Daffner K. Longitudinal assessment of pupillary sensitivity as a diagnostic marker in at-risk community dwelling elderly. Neurobiology of Aging. 1998; S83.
  176. Daffner KR, Mesulam MM, Holcomb .PJ, Calvo V, Rentz D, Jolesz F, Scinto LFM. The impact of frontal lobe damage on attention to novel events. Neurology. 1998; 50:A163.
  177. Rentz DM, Daffner KR, Calvo V, Sperling RA, Scinto LFM. Identifying preclinical Alzheimer’s disease in nondemented community dwelling elders. Neurobiology of Aging. 1998; S21.
  178. Rentz D, Daffner K, Calvo V, Scinto LFM. Controlling for preclinical AD in the neuropsychological assessment of elders. Neurology. 1998; 50:A161.
  179. Rentz D, Daffner K, Calvo V, Scinto L. The limits of screening tests for selecting normal community dwelling elders. Society for Neuroscience. 1997; 23:208.12.
  180. Rentz D, Daffner K, Cohen L, Scinto L. The limits of cognitive screening tests for determining sample selection in research on aging and Alzheimer's disease. Abstract presented at the Massachusetts Alzheimer’s Disease Research Center, Boston, MA. 1997.
  181. Scinto L, Rentz D, Cohen L, Beinfang D, Ransil B, Vale F, Daffner K. Test retest reliability of the pupil assay for the diagnosis of Alzheimer's disease. American Academy of Neurology, San Francisco. 1996.
  182. Scinto LF, Daffner KR, Dressler D, Ransil BI, Rentz D, Weintraub S, Mesulam M, Potter H. Response. Science. 1995 Mar 17; 267(5204):1580-1. PMID: 17808112.
    View in: PubMed
  183. Rentz D, Nora L, Kirschner K. A question of decision-making capacity: What would you do?. Topics in Stroke Rehabilitation. 1995; 1(4):81-84.
  184. Scinto L, Daffner K, Dresler D, Ransil B, Rentz D, Weintraub S, Mesulam M, Potter H. Detecting Alzheimer’s disease. Science. 1995; 267:1580-1581.
  185. Rentz D, Price B, Emre M, Troyer M, Natowicz M. Frontal lobe dementia in adult-onset metachromatic leukodystrophy with normal MRI. Presented at the 23rd Annual Meeting of the International Neuropsychological Society. 1995.
  186. Scinto L, Daffner K, Dresler D, Rentz D, Ransil B, Potter H. Hypersensitive pupillary dilation to a cholinergic antagonist as a diagnostic test for Alzheimer's disease. Iqbal K, Mortimer J, Winblad B & Wisniewski H, eds. Research Advances in Alzheimer's Disease And Related Disorders. 1995; 161-172.
  187. Tsukahara R & Rentz D. Preservation of procedural learning in Alzheimer's disease: a longitudinal study. American Psychological Association Annual Meeting, Division 40, New York. 1995.
  188. Scinto LF, Daffner KR, Dressler D, Ransil BI, Rentz D, Weintraub S, Mesulam M, Potter H. A potential noninvasive neurobiological test for Alzheimer's disease. Science. 1994 Nov 11; 266(5187):1051-4. PMID: 7973660.
    View in: PubMed
  189. Sandson TA, Manoach DS, Price BH, Rentz D, Weintraub S. Right hemisphere learning disability associated with left hemisphere dysfunction: anomalous dominance and development. J Neurol Neurosurg Psychiatry. 1994 Sep; 57(9):1129-32. PMID: 8089686; PMCID: PMC1073144.
  190. Price B, Troyer M, Emre M, Natowicz M, Rentz D. Neuropsychological profile and normal MRI in adult-onset variant of metachromatic leukodystrophy. American Neuropsychiatric Association Sixth Annual Meeting. 1994.
  191. Sandson T, Manoach D, Price B, Rentz D, Weintraub S. Right hemisphere learning disability associated with left hemisphere dysfunction: anomalous dominance in development. Journal of Neurology, Neurosurgery, Psychiatry. 1994; 57:1129-1132.
  192. Scinto L, Rentz D, Cohen L, Ransil B, Vale F, Daffner K. Pupil dilation as an early marker for Alzheimer’s disease: longitudinal findings in elderly subjects. Neurobiology of Aging. 1994; 17(45):S148.
  193. Rentz D. Management of the cognitively impaired older patient. Hartke RJ, ed. Psychological aspects of geriatric rehabilitation. 1991; 165-185.
  194. Rentz D. The neuropsychological assessment of dementia in a rehabilitation setting. Hartke RJ, ed. Psychological aspects of geriatric rehabilitation. 1991; 135-164.
  195. Rentz D. The assessment of rehabilitation potential: cognitive factors. Hartke RJ, ed. Psychological aspects of geriatric rehabilitation. 1991; 97-114.
  196. Rentz D, Moulthrop M, Luchins D. Alzheimer's disease among black Americans. Massachusetts Alzheimer's Disease Research Center, Boston, MA. 1990.
  197. Rentz D, Moulthrop M, Rupar K, Luchins D. The development of a measure for assessing rehabilitation potential in patients with Alzheimer's disease. Annual Meeting of the American Congress of Rehabilitation Medicine, San Antonio. 1989.
  198. Rupar K, Moulthrop M, Rentz D, Luchins D. Language and visuospatial deficits in rapid and slow progressors of Alzheimer's disease. International Neuropsychological Society Meeting, Vancouver, British Columbia. 1989.
  199. Moulthrop M, Noronha A, Rentz D, Luchins D. Neuropsychological findings in presumptive Creutzfeldt-Jakob disease. Paper presented at the ninth annual meeting of the National Academy of Neuropsychologists, Washington, D.C. 1989.
  200. Rentz D, Moulthrop M, Rupar K, Luchins D. The validity and clinical utility of a rapidity index in Alzheimer's disease. International Neuropsychological Society Meeting, Vancouver, British Columbia. 1989.
  201. Rentz D, Moulthrop M, Luchins D. Rapidity of disease progression in Alzheimer type dementia. Division 40 of the American Psychological Association, New York. 1987.
  202. Rentz D. Rapidity of disease progression in Alzheimer type dementia [Dissertation]. 1986.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Rentz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (273)
Explore
_
Co-Authors (71)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Tool Page Footer - Harvard Catalyst Tool Page Footer – Harvard Catalyst
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.